Netherlands
About Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. is a global pharmaceutical company specializing in the development and commercialization of innovative products for gastroenterology, dermatology, and healthtech solutions.
Key Products & Offerings
- GI Genius: An AI-powered system for real-time detection of colorectal lesions.
- Winlevi: A prescription treatment for acne vulgaris.
- Lialda/Mezavant/Mesavancol: A once-daily mesalamine tablet for ulcerative colitis remission.
- Uceris/Cortiment: An oral budesonide tablet targeting colon inflammation.
- Eleview: An injectable solution for safer gastrointestinal lesion removal.
- Lumeblue: A diagnostic drug for visualizing colorectal lesions.
- Aemcolo/Relafalk: A tablet-based treatment for travelers’ diarrhea.
- Byfavo: An intravenous sedative/anesthetic.
Pipeline & Development
- Breezula: Phase III androgen receptor inhibitor for scalp conditions.
- Rifamycin 1% enema: Phase II trial for distal ulcerative colitis and proctitis.
- Colesevelam: Preclinical studies for bile acid diarrhea.
- Cortexolone 17α-valerate-21-propionate: Phase I trial for solid tumors.
- AI Technology: GI Genius intelligent endoscopy system.
Strategic Partnerships
Cosmo collaborates with leading healthcare companies, including:
- Bausch Health
- Ferring
- China Medical System Holdings Limited
- Medtronic
- RedHill Biopharma Ltd.
- Sun Pharmaceutical Industries Ltd.
- 3SBio
- InfectoPharm
- Hyphens Pharma International Limited
Company Background
Founded in 1997, Cosmo Pharmaceuticals N.V. is headquartered in Dublin, Ireland.
